In the news release, Nanalysis Scientific Corp. to Present at NobleCon18, issued 13-Apr-2022 by Nanalysis Scientific Corp. over CNW, we are advised by the company that the date in the first sentence is incorrect. "Wed, April 22nd" should read "Wed, April 20th" as originally issued inadvertently. The complete, corrected release follows:
Nanalysis Scientific Corp. to Present at NobleCon18
CALGARY, AB, April 13, 2022 /CNW/ - Nanalysis Scientific Corp. (TSXV:NSCI) (OTCQX:NSCIF) (FRA:1N1) ("Nanalysis" or the "Company") announces that CEO Sean Krakiwsky will present at NobleCon18, Noble Capital Markets' Eighteenth Annual Investor Conference at the Hard Rock Hotel & Casino, Hollywood, Florida on Wed, April 20th, 2022 at 12:30 PM ET in Seminole Ballroom B. There is also the opportunity to meet with Mr. Krakiwsky at his breakout sessions scheduled for Wed, April 20, 2022, at 11:30 AM ET at Table 11, Thursday, April 21st at 11:30 AM ET at Table 1, and Thursday, April 21st at 1:45 PM at Table 10.
A high-definition, video webcast of the presentation will be available the following day at the following link: https://noble.mediasite.com/Mediasite/Play/116e75104b074f3491ff20780ccca2af1d
and as part of a complete catalog of presentations available at Noble Capital Markets' Conference website: www.nobleconference.com and on Channelchek www.channelchek.com the investor portal created by Noble. The webcast will be archived on the company's website, the NobleCon website and on Channelchek.com for 90 days following the event.
About Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1)
Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI', OTC and the Frankfurt exchange under the ticker symbol '1N1'. The company's business is what we term "MRI and NMR for industry". The company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. Nanalysis recently announced that it has begun selling a 100MHz device in 2020. The Company's new device will be the most powerful and most advanced compact NMR device ever brought to market.
Nanalysis devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.
With the recent acquisition of K'(Prime) Technologies Inc. (KPrime), the company maintains a North American sales and service company of over 40 individuals who cover scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications.
About Noble Capital Markets, Inc.
Noble Capital Markets ("Noble") is a research driven investment bank that has supported small & microcap companies since 1984. As a FINRA and SEC licensed broker dealer Noble provides institutional-quality equity research, merchant and investment banking, and order execution services. In 2005, Noble established NobleCon, an investor conference that has grown substantially over the last decade. Noble launched www.channelchek.com in 2018 - an investor community dedicated exclusively to public small and micro-cap companies and their industries. Channelchek is the first service to offer institutional-quality research to the public, for FREE at every level without a subscription. More than 6,000 public emerging growth companies are listed on the site, with growing content including research, webcasts, podcasts, and balanced news.
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law pertaining to the following: the Option and other matters ancillary or incidental to the foregoing. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-scientific-corp-to-present-at-noblecon18-301525160.html
SOURCE Nanalysis Scientific Corp.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2022/13/c3527.html